Related Experiment Videos

Production and characterization of monoclonal antibodies against the Epstein-Barr virus membrane antigen

B C Strnad, T Schuster, R Klein

    Journal of Virology
    |January 1, 1982
    PubMed

    Insights

    Researchers developed five monoclonal antibodies targeting Epstein-Barr virus membrane antigen (MA). These antibodies target specific MA components and demonstrate potential in neutralizing the virus and mediating cell lysis, offering insights into Epstein-Barr virus (EBV) infection mechanisms.

    Area of Science:

    • Immunology
    • Virology
    • Molecular Biology

    Background:

    • Epstein-Barr virus (EBV) is a significant human pathogen.
    • Understanding EBV membrane antigens (MA) is crucial for developing therapeutic strategies.
    • Hybridoma technology enables the production of specific monoclonal antibodies.

    Purpose of the Study:

    • To establish murine hybridoma lines producing monoclonal antibodies against Epstein-Barr virus membrane antigen (MA).
    • To characterize the specificity and functional activity of these novel antibodies.

    Main Methods:

    • Generation of five murine hybridoma lines.
    • Immunoprecipitation assays to determine antibody binding targets.
    • Complement-dependent cytolysis assays.
    • Viral neutralization assays.

    Main Results:

    • Three antibodies recognized both 236K MA and 212K MA.
    • Two antibodies recognized 86K MA.
    • Antibodies against 236K-212K MA and 86K MA induced complement-dependent cytolysis of EBV-infected cells.
    • Antibodies against 86K MA neutralized B95-8 and P3HR-1 EBV strains.

    Conclusions:

    • Established monoclonal antibodies against distinct Epstein-Barr virus membrane antigens.
    • Demonstrated the potential of these antibodies in mediating viral cell lysis and neutralization.
    • These findings contribute to the development of diagnostic and therapeutic tools for EBV infections.

    Related Concept Videos